Claims
- 1. A compound of the formula: ##STR4## wherein R.sub.1 is cycloalkyl having from 3-6 carbon atoms; wherein R.sub.2 and R.sub.3 are each individually selected from the group consisting of hydrogen and alkyl having from 1-4 carbon atoms; and pharmaceutically acceptable salts thereof.
- 2. The compound according to claim 1, N',N'"-2,6-anthraquinonylenebis[N,N-diethyl cyclopropanecarboxamidine].
- 3. The compound according to claim 1, N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl cyclobutanecarboxamidine].
- 4. The compound according to claim 1, N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl cyclopropanecarboxamidine].
- 5. The compound, N',N'"-2,6-anthraquinonylenebis-[N,N-dimethyl-p-chlorobenzamidine].
- 6. A method of treating cecal and hepatic amebic infections in warm-blooded animals which comprises administering to said animals an amount effective against said infections of a compound of the formula: ##STR5## wherein R.sub.1 is cycloalkyl having from 3-6 carbon atoms; wherein R.sub.2 and R.sub.3 are each individually selected from the group consisting of hydrogen and alkyl having from 1-4 carbon atoms; and pharmaceutically acceptable salts thereof.
- 7. The method according to claim 6, wherein the compound is N',N'"-2,6-anthraquinonylenebis[N,N-diethyl cyclopropanecarboxamidine].
- 8. The method according to claim 6, wherein the compound is N', N'"-2,6-anthraquinonylenebis[N,N-dimethyl cyclobutanecarboxamidine].
- 9. The method according to claim 6, wherein the compound is N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl cyclopropanecarboxamidine].
- 10. A method of treating cecal and hepatic amebic infections in warm-blooded animals which comprises administering to said animals an amount effective against said infections of N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl-p-chlorobenzamidine].
- 11. A therapeutic composition in unit dosage form which is useful for ameliorating cecal and hepatic amebic infections in warm-blooded animals comprising a compound of the formula: ##STR6## wherein R.sub.1 is cycloalkyl having from 3-6 carbon atoms; wherein R.sub.2 and R.sub.3 are each individually selected from the group consisting of hydrogen and alkyl having from 1-4 carbon atoms; and pharmaceutically acceptable salts thereof in concentrations per dosage unit sufficient to provide a daily dosage of from about 140 mg. to about 2.0 g and a pharmaceutical carrier.
- 12. A therapeutic composition in unit dosage form which is useful for ameliorating cecal and hepatic amebic infections in warm-blooded animals comprising N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl-p-chlorobenzamidine]and pharmaceutically acceptable salts thereof in concentrations per dosage unit sufficient to provide a daily dosage from about 140 mg to about 2.0 g and a pharmaceutical carrier.
- 13. The compound, N',N'"-2,6-anthraquinonylenebis[N,N-dimethyl-p-fluorobenzamidine].
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of our co-pending application Ser. No. 705,312, filed July 14, 1976, now abandoned, which in turn is a continuation-in-part of our prior application, Ser. No. 606,805, filed Aug. 22, 1975, and now abandoned.
US Referenced Citations (5)
Foreign Referenced Citations (1)
Number |
Date |
Country |
540870 |
Oct 1955 |
BEX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
705312 |
Jul 1976 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
606805 |
Aug 1975 |
|